DEUTSCHE BANK AG\

Bank

Position in FBRX — Forte Biosciences, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in FBRX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$409,508

+$356,549 QoQ

Shares Held

19,271

+1228.1% QoQ

Ownership

0.091%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 85 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. FBRX ranks #191 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$409,508	19,271	-46.9%	Shares	Defined	2026-08-07
2022-03-31	$52,959	36,274	-43.4%	Shares	Defined	2022-05-13
2021-12-31	$137,066	64,050	+683.0%	Shares	Defined	2022-02-16
2021-09-30	$24,211	8,180	-21.0%	Shares	Defined	2021-11-04
2021-06-30	$347,966	10,350	+229.6%	Shares	Defined	2021-08-11
2021-03-31	$107,607	3,140	0.0%	Shares	Defined	2021-05-13
2020-12-31	$114,327	3,140	0.0%	Shares	Defined	2021-02-16
2020-09-30	$152,321	3,140	-7.1%	Shares	Defined	2020-11-12
2020-06-30	$49,280	3,380	—	Shares	Defined	2020-08-13
2020-03-31 TOCA	—	54,167	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.